| 4959 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, August 30, 2010 |
null |
| Sex Transm Dis. | 0.793419 |
| Prue CE | 0.702688 |
| emergency department summary | 0.701352 |
| parenteral medication vials | 0.691816 |
| Aug | 0.935074 |
| Ann Intern Med. | 0.691431 |
| Matern Child Health | 0.792595 |
| CDC Science Clips | 0.854525 |
| Ann Occup Hyg. | 0.695895 |
| Method Innov Online. | 0.699832 |
| health department staff | 0.72322 |
| extremity motor performance | 0.709659 |
| new weekly digest | 0.706331 |
| acid formative research | 0.69327 |
| Chief Science Officer | 0.714991 |
| prostate cancer patients | 0.700786 |
| National Hospital Ambulatory | 0.70527 |
| antiviral prescribing practices | 0.714085 |
| early gestational age | 0.691057 |
| Stefaniak AB | 0.700353 |
| Stephen B. Thacker | 0.808981 |
| nursing assistants | 0.705617 |
| young Latina adults | 0.698412 |
| immunodeficiency virus prevention | 0.712232 |
| homebound older adults | 0.694329 |
|
| active injection-drug users | 0.689876 |
| Florida syphilis epidemic | 0.699288 |
| population-based cohort study | 0.704984 |
| road user type | 0.696468 |
| United States | 0.795688 |
| BMC Infect Dis. | 0.703537 |
| tuberculosis infection prevalence | 0.698977 |
| Pediatr Allergy Immunol. | 0.698642 |
| certified nursing assistants | 0.695714 |
| recombinant antigen-based serologies | 0.691881 |
| Child Health J. | 0.78479 |
| H.E.L.P. tool kit | 0.697904 |
| Industry-wide medical surveillance | 0.692089 |
| Brown MJ | 0.694827 |
| Birth cohort effect | 0.701764 |
| public health literature | 0.701343 |
| B. Thacker CDC | 0.851513 |
| high school students | 0.689034 |
| Medical Care Survey | 0.71067 |
| 2008-09 influenza seasons | 0.721538 |
| Hospice Care Survey | 0.70407 |
| U.S. nursing homes | 0.703632 |
| flavor manufacturing workers | 0.689242 |
| Clin Vaccine Immunol. | 0.849493 |
|
CLICK HERE |
| 5094 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, May 17, 2010 |
null |
| gynecological health care | 0.425059 |
| current awareness | 0.305556 |
| Bogalusa Heart Study | 0.448209 |
| health education needs | 0.427769 |
| intergenerational transfer | 0.318304 |
| Disease Control | 0.304665 |
| Hintz PJ | 0.325582 |
| Ann Occup Hyg. | 0.601071 |
| CDC Knowledge | 0.592138 |
| Brucella inopinata sp. | 0.425976 |
| HIV status | 0.322148 |
| Hoover DM | 0.315977 |
| Action Science Clips | 0.953991 |
| breast implant infection | 0.398281 |
| Laboratory services | 0.312139 |
| factual accuracy | 0.308223 |
| Inhorn SL | 0.307259 |
| Hauser AR | 0.3152 |
| Chief Science Officer | 0.445827 |
| policy change | 0.319803 |
| national surveys | 0.307412 |
| gestational diabetes mellitus | 0.408629 |
| Clin Infect Dis. | 0.431915 |
| DHHS | 0.32992 |
| public domain | 0.337646 |
|
| Stephen B. Thacker | 0.648945 |
| Diaz MH | 0.318676 |
| Culex mosquitoes | 0.323482 |
| Wilcke Jr BW | 0.408056 |
| skinfold thicknesses | 0.338464 |
| United States | 0.320058 |
| mobile services | 0.320101 |
| CDC case study | 0.588335 |
| middle-aged adults | 0.336171 |
| African American women | 0.415089 |
| East Baton Rouge | 0.391699 |
| Ann Hum Biol. | 0.433888 |
| federal partners | 0.316952 |
| public health literature | 0.411968 |
| status report | 0.311916 |
| B. Thacker CDC | 0.813203 |
| original authors | 0.309584 |
| non-CDC Websites | 0.306018 |
| HIV counseling | 0.319177 |
| scientific basis | 0.31273 |
| original sources | 0.339382 |
| isolation precautions | 0.317566 |
| Hurricane Katrina evacuees | 0.419237 |
| news sources | 0.312557 |
|
CLICK HERE |
| 6053 |
Centers for Disease Control and Prevention |
Html |
en |
Isophorone diisocyanate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6435 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, December 05, 2011 |
null |
| Science Clips | 0.900887 |
| current awareness | 0.224816 |
| informational purposes | 0.217279 |
| Chief Science Officer | 0.349834 |
| public health literature | 0.324435 |
| SFX server | 0.248505 |
| B. Thacker CDC | 0.765127 |
| SFX window | 0.247333 |
| full-text link | 0.231568 |
| original authors | 0.220784 |
| DHHS | 0.252412 |
|
| non-CDC Websites | 0.221534 |
| original sources | 0.227067 |
| Disease Control | 0.223073 |
| CDC Science Clips | 0.693763 |
| public domain | 0.231961 |
| CDC licensed materials | 0.519194 |
| news sources | 0.21852 |
| Stephen B. Thacker | 0.592037 |
| factual accuracy | 0.226842 |
| Thacker CDC Library | 0.756675 |
|
CLICK HERE |
| 7060 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Iraq |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 8371 |
Centers for Disease Control and Prevention |
Html |
en |
Prevention and Control of Meningococcal Disease |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| meningococcal disease epidemiology | 0.565285 |
| meningococcal capsular polysaccharide | 0.554336 |
| quadrivalent meningococcal polysaccharide-protein | 0.554131 |
| bivalent meningococcal polysaccharide | 0.576311 |
| meningococcal infection | 0.553436 |
| meningococcal vaccination | 0.677619 |
| pneumococcal conjugate vaccine | 0.517705 |
| adolescents | 0.523377 |
| meningococcal vaccine recommendations | 0.607912 |
| meningococcal polysaccharide-protein conjugate | 0.595172 |
| vaccine effectiveness | 0.585468 |
| meningococcal disease | 0.937972 |
| persons | 0.62914 |
| meningococcal capsular polysaccharides | 0.535863 |
| quadrivalent meningococcal polysaccharide | 0.633412 |
| dose | 0.551892 |
| infant meningococcal vaccine | 0.593933 |
| booster dose | 0.537001 |
| meningococcal polysaccharide vaccines | 0.565413 |
| meningococcal monovalent | 0.520454 |
| single dose | 0.545757 |
| Meningococcal Vaccines Work | 0.564097 |
| meningococcal vaccine | 0.691059 |
| invasive meningococcal disease | 0.56548 |
|
| United States | 0.747402 |
| meningococcal outbreaks | 0.526384 |
| N. meningitidis | 0.593056 |
| pathogenic meningococcal strain | 0.530877 |
| meningococcal vaccines | 0.680919 |
| meningococcal C conjugate | 0.525654 |
| U.S.-licensed meningococcal vaccine | 0.583447 |
| bactericidal antibody | 0.526257 |
| meningococcal disease peaks | 0.561423 |
| meningococcal conjugate vaccine | 0.80662 |
| meningococcal vaccine-naУÐ?ve subjects | 0.523413 |
| quadrivalent meningococcal conjugate | 0.572717 |
| meningococcal conjugate vaccination | 0.58166 |
| serogroup-specific meningococcal disease | 0.555591 |
| titers т‰Ѕ1 | 0.520059 |
| meningococcal conjugate vaccines | 0.66122 |
| unpublished data | 0.550618 |
| United Kingdom | 0.522749 |
| MenACWY conjugate vaccine | 0.512449 |
| adverse events | 0.558981 |
| MenACWY-D | 0.548119 |
| meningococcal serogroup | 0.549283 |
| meningococcal serogroups | 0.610455 |
| Meningococcal vaccination coverage | 0.548763 |
|
CLICK HERE |
| 9763 |
Centers for Disease Control and Prevention |
Html |
en |
Comorbidity in Adults with Epilepsy - United States,2010 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| epilepsy | 0.962708 |
| Figure). | 0.573331 |
| common medical comorbidities | 0.385936 |
| disease self-management programs | 0.454077 |
| medical comorbidities | 0.415617 |
| adults | 0.652287 |
| especially active epilepsy | 0.650913 |
| Human Services | 0.379647 |
| nonpsychiatric comorbidities | 0.369469 |
| National Health Interview | 0.468925 |
| health-care providers | 0.416783 |
| NHIS Sample Adult | 0.414474 |
| mental health disorder | 0.363745 |
| active epilepsy | 0.821815 |
| community epilepsy groups | 0.583385 |
| multiple chronic conditions | 0.404519 |
| U.S. Department | 0.379751 |
| disorders | 0.382735 |
| Epilepsy Foundation | 0.632181 |
| heart disease | 0.444906 |
| non-institutionalized U.S. population | 0.366926 |
| health promotion resources | 0.419644 |
| epilepsy specialist | 0.568336 |
| epilepsy management | 0.614949 |
|
| peptic ulcer disease | 0.367582 |
| sample adult component | 0.415011 |
| epilepsy groups | 0.662982 |
| chronic disease self-management | 0.45411 |
| risk factors | 0.382994 |
| epilepsy manage | 0.567036 |
| self-reported heart disease | 0.365044 |
| epilepsy incidence | 0.558474 |
| response rate | 0.380844 |
| U.S. adults | 0.40043 |
| epilepsy providers | 0.59479 |
| Health Interview Survey | 0.468247 |
| Chronic Disease Prevention | 0.371339 |
| liver condition | 0.387517 |
| local Epilepsy Foundation | 0.58199 |
| epilepsy status | 0.61472 |
| epilepsy prevalence | 0.573207 |
| high blood pressure | 0.40687 |
| inactive epilepsy | 0.697418 |
| Table). | 0.58765 |
| coronary heart disease | 0.394515 |
| representative U.S. sample | 0.369819 |
| public health agencies | 0.456091 |
|
CLICK HERE |
| 11330 |
Centers for Disease Control and Prevention |
Html |
en |
Program Evaluation |
This page provides tools and resources for researching and evaluating health literacy practice. |
| CDC’s Framework | 0.445324 |
| teach-back method | 0.414339 |
| public health effectiveness | 0.53156 |
| communication data | 0.423602 |
| type | 0.322904 |
| patient knowledge | 0.41414 |
| outcomes | 0.327168 |
| Proportion | 0.326202 |
| Example | 0.461456 |
| context | 0.349453 |
| clinicians | 0.322138 |
| communication | 0.528849 |
| results | 0.327362 |
| patient-centered measures | 0.468602 |
| area | 0.323066 |
| data sources | 0.412308 |
| level | 0.322891 |
| judgments | 0.327862 |
| healthcare team members | 0.511448 |
| available evidence | 0.43071 |
| community | 0.321003 |
| standards | 0.346463 |
| provider module | 0.417828 |
| Roadmap | 0.326833 |
| health literacy | 0.943504 |
|
| Goals | 0.321577 |
| lessons | 0.322315 |
| health literacy measures | 0.820322 |
| strong evaluation approach | 0.541619 |
| aspects | 0.323105 |
| description | 0.32528 |
| program performance | 0.525875 |
| specific health literacy | 0.560078 |
| health literacy programs | 0.569355 |
| inquiry | 0.32164 |
| systems | 0.321345 |
| value | 0.342476 |
| program efforts | 0.436318 |
| types | 0.321358 |
| strategies | 0.321564 |
| patient questions | 0.408752 |
| patient contact | 0.415584 |
| possible sources | 0.439496 |
| activities | 0.344799 |
| organization | 0.322059 |
| elements | 0.321597 |
| communication measures | 0.465511 |
| care plan | 0.416728 |
| evaluation process | 0.443364 |
|
CLICK HERE |
| 12097 |
Centers for Disease Control and Prevention |
Html |
en |
Vital Signs: HIV Diagnosis, Care, and Treatment AmongPersons Living with HIV - United States, 2011 |
On November 25, 2014, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr). |
| Medical Monitoring Project | 0.212876 |
| new HIV infections | 0.287747 |
| ART | 0.232148 |
| United States | 0.357937 |
| undiagnosed HIV infections | 0.320093 |
| early HIV treatment | 0.232422 |
| HIV medical care | 0.938716 |
| hiv diagnosis | 0.332324 |
| National HIV Surveillance | 0.291029 |
| HIV surveillance data | 0.231562 |
|
| persons | 0.402283 |
| viral load | 0.396811 |
| undiagnosed HIV infection | 0.239988 |
| HIV viral load | 0.264694 |
| viral suppression | 0.573241 |
| HIV testing | 0.241816 |
| HIV care continuum | 0.597636 |
| HIV infection | 0.491408 |
| HIV transmission | 0.279298 |
|
CLICK HERE |
| 12439 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Social Media in CommunicatingHealth Information: An Analysis of Facebook Groups Related toHypertension - CDC |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange on the very latest in chronic disease prevention, research findings, public health interventions, and the exploration of new theories and concepts.
|
| open Facebook groups | 0.479423 |
| health professional groups | 0.362616 |
| stepwise logistic regression | 0.413603 |
| Online support groups | 0.368024 |
| disease experience-sharing groups | 0.355353 |
| main objective | 0.377848 |
| Facebook group members | 0.419862 |
| social network site | 0.356807 |
| recent wall post | 0.594833 |
| hypertension awareness | 0.411716 |
| idiopathic pulmonary hypertension | 0.358325 |
| analyzed Facebook groups | 0.438854 |
| Facebook community | 0.424811 |
| Facebook groups | 0.906362 |
| hypertension-related open Facebook | 0.412391 |
| Facebook search box | 0.426273 |
| hypertension-related groups | 0.366919 |
| study | 0.389134 |
| diabetes-related Facebook groups | 0.433505 |
| experience-sharing groups | 0.356857 |
| cancer-related Facebook groups | 0.447649 |
| English hypertension-related Facebook | 0.410311 |
| top-displayed recent post | 0.354433 |
| awareness-creating groups | 0.356912 |
|
| total number | 0.355747 |
| Facebook pages | 0.42829 |
| Singapore Hypertension Club | 0.35986 |
| hypertension groups | 0.388664 |
| social media | 0.411078 |
| Facebook feature | 0.409756 |
| health professionals groups | 0.365368 |
| pulmonary arterial hypertension | 0.358384 |
| community hypertension programs | 0.358859 |
| Facebook account | 0.407862 |
| breast cancer-related Facebook | 0.423918 |
| product promotion groups | 0.358212 |
| health | 0.374615 |
| support groups | 0.396597 |
| Facebook users | 0.420847 |
| hypertension-related Facebook groups | 0.710536 |
| high blood pressure | 0.487724 |
| Facebook group walls | 0.418745 |
| social media sites | 0.398764 |
| Hypertension Support Group | 0.37728 |
| recent wall posts | 0.422689 |
| top-displayed recent wall | 0.405482 |
| open groups | 0.363268 |
| group size | 0.35662 |
|
CLICK HERE |